Global Neonatal Genetic Disease Diagnosis Supply, Demand and Key Producers, 2026-2032
The global Neonatal Genetic Disease Diagnosis market size is expected to reach $ 3844 million by 2032, rising at a market growth of 9.6% CAGR during the forecast period (2026-2032).
In 2025, global Neonatal Genetic Disease Diagnosis production reached approximately 10.59 million tests, with an average global market price of around USD 185 per test.
The gross profit margin of major companies in the industry is between 32.45%?55.36%.
In 2025, the global production capacity of Neonatal Genetic Disease Diagnosis was approximately 13.94 million tests.
Neonatal Genetic Disease Diagnosis refers to genetic testing and related diagnostic services used to identify inherited or congenital diseases in newborns. It may involve targeted panels, sequencing, copy number analysis, biochemical confirmation and clinical interpretation based on blood spots, blood samples or other neonatal specimens. The product scope covers diagnostic test kits, laboratory-developed testing services, sequencing-based screening and confirmatory genetic diagnosis for newborn diseases. It excludes prenatal testing, adult genetic testing, routine biochemical newborn screening without genetic analysis and general pediatric diagnostics unrelated to inherited disease.
The industry chain includes sample collection materials, nucleic acid extraction reagents, sequencing reagents, assay kits, bioinformatics tools, laboratory instruments, databases and quality control materials. Midstream activities include sample processing, genetic testing, data analysis, variant interpretation, report generation and clinical consultation. Downstream users include hospitals, newborn screening centers, clinical laboratories, pediatric departments, public health programs and families. Demand is driven by early disease detection, declining sequencing costs, expanded screening panels, rare disease awareness and healthcare policies supporting early intervention.
Improved national prenatal and newborn healthcare system plus birth defect prevention policies expand neonatal genetic disease diagnosis market. Early screening achieves timely intervention to reduce congenital disease incidence. High-throughput testing technology continuously improves detection coverage and accuracy.
This report studies the global Neonatal Genetic Disease Diagnosis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neonatal Genetic Disease Diagnosis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neonatal Genetic Disease Diagnosis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neonatal Genetic Disease Diagnosis total market, 2021-2032, (USD Million)
Global Neonatal Genetic Disease Diagnosis total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Neonatal Genetic Disease Diagnosis total market, key domestic companies, and share, (USD Million)
Global Neonatal Genetic Disease Diagnosis revenue by player, revenue and market share 2021-2026, (USD Million)
Global Neonatal Genetic Disease Diagnosis total market by Type, CAGR, 2021-2032, (USD Million)
Global Neonatal Genetic Disease Diagnosis total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Neonatal Genetic Disease Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneDx, Revvity, Labcorp, Quest Diagnostics, Centogene, Baylor Genetics, Fulgent Genetics, ARUP Laboratories, BGI Genomics, Berry Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Neonatal Genetic Disease Diagnosis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Neonatal Genetic Disease Diagnosis Market, By Region:
1. How big is the global Neonatal Genetic Disease Diagnosis market?
2. What is the demand of the global Neonatal Genetic Disease Diagnosis market?
3. What is the year over year growth of the global Neonatal Genetic Disease Diagnosis market?
4. What is the total value of the global Neonatal Genetic Disease Diagnosis market?
5. Who are the Major Players in the global Neonatal Genetic Disease Diagnosis market?
6. What are the growth factors driving the market demand?
In 2025, global Neonatal Genetic Disease Diagnosis production reached approximately 10.59 million tests, with an average global market price of around USD 185 per test.
The gross profit margin of major companies in the industry is between 32.45%?55.36%.
In 2025, the global production capacity of Neonatal Genetic Disease Diagnosis was approximately 13.94 million tests.
Neonatal Genetic Disease Diagnosis refers to genetic testing and related diagnostic services used to identify inherited or congenital diseases in newborns. It may involve targeted panels, sequencing, copy number analysis, biochemical confirmation and clinical interpretation based on blood spots, blood samples or other neonatal specimens. The product scope covers diagnostic test kits, laboratory-developed testing services, sequencing-based screening and confirmatory genetic diagnosis for newborn diseases. It excludes prenatal testing, adult genetic testing, routine biochemical newborn screening without genetic analysis and general pediatric diagnostics unrelated to inherited disease.
The industry chain includes sample collection materials, nucleic acid extraction reagents, sequencing reagents, assay kits, bioinformatics tools, laboratory instruments, databases and quality control materials. Midstream activities include sample processing, genetic testing, data analysis, variant interpretation, report generation and clinical consultation. Downstream users include hospitals, newborn screening centers, clinical laboratories, pediatric departments, public health programs and families. Demand is driven by early disease detection, declining sequencing costs, expanded screening panels, rare disease awareness and healthcare policies supporting early intervention.
Improved national prenatal and newborn healthcare system plus birth defect prevention policies expand neonatal genetic disease diagnosis market. Early screening achieves timely intervention to reduce congenital disease incidence. High-throughput testing technology continuously improves detection coverage and accuracy.
This report studies the global Neonatal Genetic Disease Diagnosis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neonatal Genetic Disease Diagnosis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neonatal Genetic Disease Diagnosis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neonatal Genetic Disease Diagnosis total market, 2021-2032, (USD Million)
Global Neonatal Genetic Disease Diagnosis total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Neonatal Genetic Disease Diagnosis total market, key domestic companies, and share, (USD Million)
Global Neonatal Genetic Disease Diagnosis revenue by player, revenue and market share 2021-2026, (USD Million)
Global Neonatal Genetic Disease Diagnosis total market by Type, CAGR, 2021-2032, (USD Million)
Global Neonatal Genetic Disease Diagnosis total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Neonatal Genetic Disease Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneDx, Revvity, Labcorp, Quest Diagnostics, Centogene, Baylor Genetics, Fulgent Genetics, ARUP Laboratories, BGI Genomics, Berry Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Neonatal Genetic Disease Diagnosis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Neonatal Genetic Disease Diagnosis Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Targeted Gene Panel Testing
- Whole Exome Sequencing
- Whole Genome Sequencing
- Inherited Metabolic Disease Diagnosis
- Primary Immunodeficiency Diagnosis
- Neuromuscular and Developmental Disorder Diagnosis
- Rapid Diagnosis??7 days?
- Standard Diagnosis?8?21 days?
- Extended Diagnosis??21 days?
- Hospitals
- Third-Party Clinical Laboratories
- Public Health Screening Centers
- Other
- GeneDx
- Revvity
- Labcorp
- Quest Diagnostics
- Centogene
- Baylor Genetics
- Fulgent Genetics
- ARUP Laboratories
- BGI Genomics
- Berry Genomics
- Annoroad Gene Technology
- CapitalBio Technology
- KingMed Diagnostics
- Novogene
- Da An Gene
1. How big is the global Neonatal Genetic Disease Diagnosis market?
2. What is the demand of the global Neonatal Genetic Disease Diagnosis market?
3. What is the year over year growth of the global Neonatal Genetic Disease Diagnosis market?
4. What is the total value of the global Neonatal Genetic Disease Diagnosis market?
5. Who are the Major Players in the global Neonatal Genetic Disease Diagnosis market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Neonatal Genetic Disease Diagnosis Introduction
1.2 World Neonatal Genetic Disease Diagnosis Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Neonatal Genetic Disease Diagnosis Total Market by Region (by Headquarter Location)
1.3.1 World Neonatal Genetic Disease Diagnosis Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.3.3 China Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.3.4 Europe Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.3.5 Japan Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.3.6 South Korea Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.3.7 ASEAN Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.3.8 India Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neonatal Genetic Disease Diagnosis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.2 World Neonatal Genetic Disease Diagnosis Consumption Value by Region
2.2.1 World Neonatal Genetic Disease Diagnosis Consumption Value by Region (2021-2026)
2.2.2 World Neonatal Genetic Disease Diagnosis Consumption Value Forecast by Region (2027-2032)
2.3 United States Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.4 China Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.5 Europe Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.6 Japan Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.7 South Korea Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.8 ASEAN Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.9 India Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
3 WORLD NEONATAL GENETIC DISEASE DIAGNOSIS COMPANIES COMPETITIVE ANALYSIS
3.1 World Neonatal Genetic Disease Diagnosis Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neonatal Genetic Disease Diagnosis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neonatal Genetic Disease Diagnosis in 2025
3.2.3 Global Concentration Ratios (CR8) for Neonatal Genetic Disease Diagnosis in 2025
3.3 Neonatal Genetic Disease Diagnosis Company Evaluation Quadrant
3.4 Neonatal Genetic Disease Diagnosis Market: Overall Company Footprint Analysis
3.4.1 Neonatal Genetic Disease Diagnosis Market: Region Footprint
3.4.2 Neonatal Genetic Disease Diagnosis Market: Company Product Type Footprint
3.4.3 Neonatal Genetic Disease Diagnosis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Neonatal Genetic Disease Diagnosis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neonatal Genetic Disease Diagnosis Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Neonatal Genetic Disease Diagnosis Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Neonatal Genetic Disease Diagnosis Consumption Value Comparison
4.2.1 United States VS China: Neonatal Genetic Disease Diagnosis Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Neonatal Genetic Disease Diagnosis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Neonatal Genetic Disease Diagnosis Companies and Market Share, 2021-2026
4.3.1 United States Based Neonatal Genetic Disease Diagnosis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neonatal Genetic Disease Diagnosis Revenue, (2021-2026)
4.4 China Based Companies Neonatal Genetic Disease Diagnosis Revenue and Market Share, 2021-2026
4.4.1 China Based Neonatal Genetic Disease Diagnosis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neonatal Genetic Disease Diagnosis Revenue, (2021-2026)
4.5 Rest of World Based Neonatal Genetic Disease Diagnosis Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Neonatal Genetic Disease Diagnosis Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Neonatal Genetic Disease Diagnosis Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Neonatal Genetic Disease Diagnosis Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Targeted Gene Panel Testing
5.2.2 Whole Exome Sequencing
5.2.3 Whole Genome Sequencing
5.3 Market Segment by Type
5.3.1 World Neonatal Genetic Disease Diagnosis Market Size by Type (2021-2026)
5.3.2 World Neonatal Genetic Disease Diagnosis Market Size by Type (2027-2032)
5.3.3 World Neonatal Genetic Disease Diagnosis Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DISEASE COVERAGE
6.1 World Neonatal Genetic Disease Diagnosis Market Size Overview by Disease Coverage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Disease Coverage
6.2.1 Inherited Metabolic Disease Diagnosis
6.2.2 Primary Immunodeficiency Diagnosis
6.2.3 Neuromuscular and Developmental Disorder Diagnosis
6.3 Market Segment by Disease Coverage
6.3.1 World Neonatal Genetic Disease Diagnosis Market Size by Disease Coverage (2021-2026)
6.3.2 World Neonatal Genetic Disease Diagnosis Market Size by Disease Coverage (2027-2032)
6.3.3 World Neonatal Genetic Disease Diagnosis Market Size Market Share by Disease Coverage (2027-2032)
7 MARKET ANALYSIS BY TURNAROUND TIME
7.1 World Neonatal Genetic Disease Diagnosis Market Size Overview by Turnaround Time: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Turnaround Time
7.2.1 Rapid Diagnosis??7 days?
7.2.2 Standard Diagnosis?8?21 days?
7.2.3 Extended Diagnosis??21 days?
7.3 Market Segment by Turnaround Time
7.3.1 World Neonatal Genetic Disease Diagnosis Market Size by Turnaround Time (2021-2026)
7.3.2 World Neonatal Genetic Disease Diagnosis Market Size by Turnaround Time (2027-2032)
7.3.3 World Neonatal Genetic Disease Diagnosis Market Size Market Share by Turnaround Time (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Neonatal Genetic Disease Diagnosis Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Third-Party Clinical Laboratories
8.2.3 Public Health Screening Centers
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Neonatal Genetic Disease Diagnosis Market Size by Application (2021-2026)
8.3.2 World Neonatal Genetic Disease Diagnosis Market Size by Application (2027-2032)
8.3.3 World Neonatal Genetic Disease Diagnosis Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 GeneDx
9.1.1 GeneDx Details
9.1.2 GeneDx Major Business
9.1.3 GeneDx Neonatal Genetic Disease Diagnosis Product and Services
9.1.4 GeneDx Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 GeneDx Recent Developments/Updates
9.1.6 GeneDx Competitive Strengths & Weaknesses
9.2 Revvity
9.2.1 Revvity Details
9.2.2 Revvity Major Business
9.2.3 Revvity Neonatal Genetic Disease Diagnosis Product and Services
9.2.4 Revvity Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Revvity Recent Developments/Updates
9.2.6 Revvity Competitive Strengths & Weaknesses
9.3 Labcorp
9.3.1 Labcorp Details
9.3.2 Labcorp Major Business
9.3.3 Labcorp Neonatal Genetic Disease Diagnosis Product and Services
9.3.4 Labcorp Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Labcorp Recent Developments/Updates
9.3.6 Labcorp Competitive Strengths & Weaknesses
9.4 Quest Diagnostics
9.4.1 Quest Diagnostics Details
9.4.2 Quest Diagnostics Major Business
9.4.3 Quest Diagnostics Neonatal Genetic Disease Diagnosis Product and Services
9.4.4 Quest Diagnostics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Quest Diagnostics Recent Developments/Updates
9.4.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.5 Centogene
9.5.1 Centogene Details
9.5.2 Centogene Major Business
9.5.3 Centogene Neonatal Genetic Disease Diagnosis Product and Services
9.5.4 Centogene Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Centogene Recent Developments/Updates
9.5.6 Centogene Competitive Strengths & Weaknesses
9.6 Baylor Genetics
9.6.1 Baylor Genetics Details
9.6.2 Baylor Genetics Major Business
9.6.3 Baylor Genetics Neonatal Genetic Disease Diagnosis Product and Services
9.6.4 Baylor Genetics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Baylor Genetics Recent Developments/Updates
9.6.6 Baylor Genetics Competitive Strengths & Weaknesses
9.7 Fulgent Genetics
9.7.1 Fulgent Genetics Details
9.7.2 Fulgent Genetics Major Business
9.7.3 Fulgent Genetics Neonatal Genetic Disease Diagnosis Product and Services
9.7.4 Fulgent Genetics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Fulgent Genetics Recent Developments/Updates
9.7.6 Fulgent Genetics Competitive Strengths & Weaknesses
9.8 ARUP Laboratories
9.8.1 ARUP Laboratories Details
9.8.2 ARUP Laboratories Major Business
9.8.3 ARUP Laboratories Neonatal Genetic Disease Diagnosis Product and Services
9.8.4 ARUP Laboratories Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 ARUP Laboratories Recent Developments/Updates
9.8.6 ARUP Laboratories Competitive Strengths & Weaknesses
9.9 BGI Genomics
9.9.1 BGI Genomics Details
9.9.2 BGI Genomics Major Business
9.9.3 BGI Genomics Neonatal Genetic Disease Diagnosis Product and Services
9.9.4 BGI Genomics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 BGI Genomics Recent Developments/Updates
9.9.6 BGI Genomics Competitive Strengths & Weaknesses
9.10 Berry Genomics
9.10.1 Berry Genomics Details
9.10.2 Berry Genomics Major Business
9.10.3 Berry Genomics Neonatal Genetic Disease Diagnosis Product and Services
9.10.4 Berry Genomics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Berry Genomics Recent Developments/Updates
9.10.6 Berry Genomics Competitive Strengths & Weaknesses
9.11 Annoroad Gene Technology
9.11.1 Annoroad Gene Technology Details
9.11.2 Annoroad Gene Technology Major Business
9.11.3 Annoroad Gene Technology Neonatal Genetic Disease Diagnosis Product and Services
9.11.4 Annoroad Gene Technology Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Annoroad Gene Technology Recent Developments/Updates
9.11.6 Annoroad Gene Technology Competitive Strengths & Weaknesses
9.12 CapitalBio Technology
9.12.1 CapitalBio Technology Details
9.12.2 CapitalBio Technology Major Business
9.12.3 CapitalBio Technology Neonatal Genetic Disease Diagnosis Product and Services
9.12.4 CapitalBio Technology Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 CapitalBio Technology Recent Developments/Updates
9.12.6 CapitalBio Technology Competitive Strengths & Weaknesses
9.13 KingMed Diagnostics
9.13.1 KingMed Diagnostics Details
9.13.2 KingMed Diagnostics Major Business
9.13.3 KingMed Diagnostics Neonatal Genetic Disease Diagnosis Product and Services
9.13.4 KingMed Diagnostics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 KingMed Diagnostics Recent Developments/Updates
9.13.6 KingMed Diagnostics Competitive Strengths & Weaknesses
9.14 Novogene
9.14.1 Novogene Details
9.14.2 Novogene Major Business
9.14.3 Novogene Neonatal Genetic Disease Diagnosis Product and Services
9.14.4 Novogene Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Novogene Recent Developments/Updates
9.14.6 Novogene Competitive Strengths & Weaknesses
9.15 Da An Gene
9.15.1 Da An Gene Details
9.15.2 Da An Gene Major Business
9.15.3 Da An Gene Neonatal Genetic Disease Diagnosis Product and Services
9.15.4 Da An Gene Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Da An Gene Recent Developments/Updates
9.15.6 Da An Gene Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Neonatal Genetic Disease Diagnosis Industry Chain
10.2 Neonatal Genetic Disease Diagnosis Upstream Analysis
10.3 Neonatal Genetic Disease Diagnosis Midstream Analysis
10.4 Neonatal Genetic Disease Diagnosis Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Neonatal Genetic Disease Diagnosis Introduction
1.2 World Neonatal Genetic Disease Diagnosis Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Neonatal Genetic Disease Diagnosis Total Market by Region (by Headquarter Location)
1.3.1 World Neonatal Genetic Disease Diagnosis Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.3.3 China Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.3.4 Europe Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.3.5 Japan Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.3.6 South Korea Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.3.7 ASEAN Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.3.8 India Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neonatal Genetic Disease Diagnosis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.2 World Neonatal Genetic Disease Diagnosis Consumption Value by Region
2.2.1 World Neonatal Genetic Disease Diagnosis Consumption Value by Region (2021-2026)
2.2.2 World Neonatal Genetic Disease Diagnosis Consumption Value Forecast by Region (2027-2032)
2.3 United States Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.4 China Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.5 Europe Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.6 Japan Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.7 South Korea Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.8 ASEAN Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
2.9 India Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032)
3 WORLD NEONATAL GENETIC DISEASE DIAGNOSIS COMPANIES COMPETITIVE ANALYSIS
3.1 World Neonatal Genetic Disease Diagnosis Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neonatal Genetic Disease Diagnosis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neonatal Genetic Disease Diagnosis in 2025
3.2.3 Global Concentration Ratios (CR8) for Neonatal Genetic Disease Diagnosis in 2025
3.3 Neonatal Genetic Disease Diagnosis Company Evaluation Quadrant
3.4 Neonatal Genetic Disease Diagnosis Market: Overall Company Footprint Analysis
3.4.1 Neonatal Genetic Disease Diagnosis Market: Region Footprint
3.4.2 Neonatal Genetic Disease Diagnosis Market: Company Product Type Footprint
3.4.3 Neonatal Genetic Disease Diagnosis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Neonatal Genetic Disease Diagnosis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neonatal Genetic Disease Diagnosis Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Neonatal Genetic Disease Diagnosis Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Neonatal Genetic Disease Diagnosis Consumption Value Comparison
4.2.1 United States VS China: Neonatal Genetic Disease Diagnosis Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Neonatal Genetic Disease Diagnosis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Neonatal Genetic Disease Diagnosis Companies and Market Share, 2021-2026
4.3.1 United States Based Neonatal Genetic Disease Diagnosis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neonatal Genetic Disease Diagnosis Revenue, (2021-2026)
4.4 China Based Companies Neonatal Genetic Disease Diagnosis Revenue and Market Share, 2021-2026
4.4.1 China Based Neonatal Genetic Disease Diagnosis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neonatal Genetic Disease Diagnosis Revenue, (2021-2026)
4.5 Rest of World Based Neonatal Genetic Disease Diagnosis Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Neonatal Genetic Disease Diagnosis Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Neonatal Genetic Disease Diagnosis Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Neonatal Genetic Disease Diagnosis Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Targeted Gene Panel Testing
5.2.2 Whole Exome Sequencing
5.2.3 Whole Genome Sequencing
5.3 Market Segment by Type
5.3.1 World Neonatal Genetic Disease Diagnosis Market Size by Type (2021-2026)
5.3.2 World Neonatal Genetic Disease Diagnosis Market Size by Type (2027-2032)
5.3.3 World Neonatal Genetic Disease Diagnosis Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DISEASE COVERAGE
6.1 World Neonatal Genetic Disease Diagnosis Market Size Overview by Disease Coverage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Disease Coverage
6.2.1 Inherited Metabolic Disease Diagnosis
6.2.2 Primary Immunodeficiency Diagnosis
6.2.3 Neuromuscular and Developmental Disorder Diagnosis
6.3 Market Segment by Disease Coverage
6.3.1 World Neonatal Genetic Disease Diagnosis Market Size by Disease Coverage (2021-2026)
6.3.2 World Neonatal Genetic Disease Diagnosis Market Size by Disease Coverage (2027-2032)
6.3.3 World Neonatal Genetic Disease Diagnosis Market Size Market Share by Disease Coverage (2027-2032)
7 MARKET ANALYSIS BY TURNAROUND TIME
7.1 World Neonatal Genetic Disease Diagnosis Market Size Overview by Turnaround Time: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Turnaround Time
7.2.1 Rapid Diagnosis??7 days?
7.2.2 Standard Diagnosis?8?21 days?
7.2.3 Extended Diagnosis??21 days?
7.3 Market Segment by Turnaround Time
7.3.1 World Neonatal Genetic Disease Diagnosis Market Size by Turnaround Time (2021-2026)
7.3.2 World Neonatal Genetic Disease Diagnosis Market Size by Turnaround Time (2027-2032)
7.3.3 World Neonatal Genetic Disease Diagnosis Market Size Market Share by Turnaround Time (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Neonatal Genetic Disease Diagnosis Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Third-Party Clinical Laboratories
8.2.3 Public Health Screening Centers
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Neonatal Genetic Disease Diagnosis Market Size by Application (2021-2026)
8.3.2 World Neonatal Genetic Disease Diagnosis Market Size by Application (2027-2032)
8.3.3 World Neonatal Genetic Disease Diagnosis Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 GeneDx
9.1.1 GeneDx Details
9.1.2 GeneDx Major Business
9.1.3 GeneDx Neonatal Genetic Disease Diagnosis Product and Services
9.1.4 GeneDx Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 GeneDx Recent Developments/Updates
9.1.6 GeneDx Competitive Strengths & Weaknesses
9.2 Revvity
9.2.1 Revvity Details
9.2.2 Revvity Major Business
9.2.3 Revvity Neonatal Genetic Disease Diagnosis Product and Services
9.2.4 Revvity Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Revvity Recent Developments/Updates
9.2.6 Revvity Competitive Strengths & Weaknesses
9.3 Labcorp
9.3.1 Labcorp Details
9.3.2 Labcorp Major Business
9.3.3 Labcorp Neonatal Genetic Disease Diagnosis Product and Services
9.3.4 Labcorp Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Labcorp Recent Developments/Updates
9.3.6 Labcorp Competitive Strengths & Weaknesses
9.4 Quest Diagnostics
9.4.1 Quest Diagnostics Details
9.4.2 Quest Diagnostics Major Business
9.4.3 Quest Diagnostics Neonatal Genetic Disease Diagnosis Product and Services
9.4.4 Quest Diagnostics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Quest Diagnostics Recent Developments/Updates
9.4.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.5 Centogene
9.5.1 Centogene Details
9.5.2 Centogene Major Business
9.5.3 Centogene Neonatal Genetic Disease Diagnosis Product and Services
9.5.4 Centogene Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Centogene Recent Developments/Updates
9.5.6 Centogene Competitive Strengths & Weaknesses
9.6 Baylor Genetics
9.6.1 Baylor Genetics Details
9.6.2 Baylor Genetics Major Business
9.6.3 Baylor Genetics Neonatal Genetic Disease Diagnosis Product and Services
9.6.4 Baylor Genetics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Baylor Genetics Recent Developments/Updates
9.6.6 Baylor Genetics Competitive Strengths & Weaknesses
9.7 Fulgent Genetics
9.7.1 Fulgent Genetics Details
9.7.2 Fulgent Genetics Major Business
9.7.3 Fulgent Genetics Neonatal Genetic Disease Diagnosis Product and Services
9.7.4 Fulgent Genetics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Fulgent Genetics Recent Developments/Updates
9.7.6 Fulgent Genetics Competitive Strengths & Weaknesses
9.8 ARUP Laboratories
9.8.1 ARUP Laboratories Details
9.8.2 ARUP Laboratories Major Business
9.8.3 ARUP Laboratories Neonatal Genetic Disease Diagnosis Product and Services
9.8.4 ARUP Laboratories Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 ARUP Laboratories Recent Developments/Updates
9.8.6 ARUP Laboratories Competitive Strengths & Weaknesses
9.9 BGI Genomics
9.9.1 BGI Genomics Details
9.9.2 BGI Genomics Major Business
9.9.3 BGI Genomics Neonatal Genetic Disease Diagnosis Product and Services
9.9.4 BGI Genomics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 BGI Genomics Recent Developments/Updates
9.9.6 BGI Genomics Competitive Strengths & Weaknesses
9.10 Berry Genomics
9.10.1 Berry Genomics Details
9.10.2 Berry Genomics Major Business
9.10.3 Berry Genomics Neonatal Genetic Disease Diagnosis Product and Services
9.10.4 Berry Genomics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Berry Genomics Recent Developments/Updates
9.10.6 Berry Genomics Competitive Strengths & Weaknesses
9.11 Annoroad Gene Technology
9.11.1 Annoroad Gene Technology Details
9.11.2 Annoroad Gene Technology Major Business
9.11.3 Annoroad Gene Technology Neonatal Genetic Disease Diagnosis Product and Services
9.11.4 Annoroad Gene Technology Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Annoroad Gene Technology Recent Developments/Updates
9.11.6 Annoroad Gene Technology Competitive Strengths & Weaknesses
9.12 CapitalBio Technology
9.12.1 CapitalBio Technology Details
9.12.2 CapitalBio Technology Major Business
9.12.3 CapitalBio Technology Neonatal Genetic Disease Diagnosis Product and Services
9.12.4 CapitalBio Technology Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 CapitalBio Technology Recent Developments/Updates
9.12.6 CapitalBio Technology Competitive Strengths & Weaknesses
9.13 KingMed Diagnostics
9.13.1 KingMed Diagnostics Details
9.13.2 KingMed Diagnostics Major Business
9.13.3 KingMed Diagnostics Neonatal Genetic Disease Diagnosis Product and Services
9.13.4 KingMed Diagnostics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 KingMed Diagnostics Recent Developments/Updates
9.13.6 KingMed Diagnostics Competitive Strengths & Weaknesses
9.14 Novogene
9.14.1 Novogene Details
9.14.2 Novogene Major Business
9.14.3 Novogene Neonatal Genetic Disease Diagnosis Product and Services
9.14.4 Novogene Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Novogene Recent Developments/Updates
9.14.6 Novogene Competitive Strengths & Weaknesses
9.15 Da An Gene
9.15.1 Da An Gene Details
9.15.2 Da An Gene Major Business
9.15.3 Da An Gene Neonatal Genetic Disease Diagnosis Product and Services
9.15.4 Da An Gene Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Da An Gene Recent Developments/Updates
9.15.6 Da An Gene Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Neonatal Genetic Disease Diagnosis Industry Chain
10.2 Neonatal Genetic Disease Diagnosis Upstream Analysis
10.3 Neonatal Genetic Disease Diagnosis Midstream Analysis
10.4 Neonatal Genetic Disease Diagnosis Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Neonatal Genetic Disease Diagnosis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Neonatal Genetic Disease Diagnosis Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Neonatal Genetic Disease Diagnosis Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Neonatal Genetic Disease Diagnosis Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Neonatal Genetic Disease Diagnosis Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neonatal Genetic Disease Diagnosis Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Neonatal Genetic Disease Diagnosis Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Neonatal Genetic Disease Diagnosis Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Neonatal Genetic Disease Diagnosis Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Neonatal Genetic Disease Diagnosis Players in 2025
Table 12. World Neonatal Genetic Disease Diagnosis Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Neonatal Genetic Disease Diagnosis Company Evaluation Quadrant
Table 14. Head Office of Key Neonatal Genetic Disease Diagnosis Players
Table 15. Neonatal Genetic Disease Diagnosis Market: Company Product Type Footprint
Table 16. Neonatal Genetic Disease Diagnosis Market: Company Product Application Footprint
Table 17. Neonatal Genetic Disease Diagnosis Mergers & Acquisitions Activity
Table 18. United States VS China Neonatal Genetic Disease Diagnosis Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Neonatal Genetic Disease Diagnosis Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Neonatal Genetic Disease Diagnosis Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neonatal Genetic Disease Diagnosis Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Neonatal Genetic Disease Diagnosis Revenue Market Share (2021-2026)
Table 23. China Based Neonatal Genetic Disease Diagnosis Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neonatal Genetic Disease Diagnosis Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Neonatal Genetic Disease Diagnosis Revenue Market Share (2021-2026)
Table 26. Rest of World Based Neonatal Genetic Disease Diagnosis Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Neonatal Genetic Disease Diagnosis Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Neonatal Genetic Disease Diagnosis Revenue Market Share (2021-2026)
Table 29. World Neonatal Genetic Disease Diagnosis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Neonatal Genetic Disease Diagnosis Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Neonatal Genetic Disease Diagnosis Market Size by Type (2027-2032) & (USD Million)
Table 32. World Neonatal Genetic Disease Diagnosis Market Size by Disease Coverage, (USD Million), 2021 & 2025 & 2032
Table 33. World Neonatal Genetic Disease Diagnosis Market Size Value by Disease Coverage (2021-2026) & (USD Million)
Table 34. World Neonatal Genetic Disease Diagnosis Market Size by Disease Coverage (2027-2032) & (USD Million)
Table 35. World Neonatal Genetic Disease Diagnosis Market Size by Turnaround Time, (USD Million), 2021 & 2025 & 2032
Table 36. World Neonatal Genetic Disease Diagnosis Market Size Value by Turnaround Time (2021-2026) & (USD Million)
Table 37. World Neonatal Genetic Disease Diagnosis Market Size by Turnaround Time (2027-2032) & (USD Million)
Table 38. World Neonatal Genetic Disease Diagnosis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Neonatal Genetic Disease Diagnosis Market Size by Application (2021-2026) & (USD Million)
Table 40. World Neonatal Genetic Disease Diagnosis Market Size by Application (2027-2032) & (USD Million)
Table 41. GeneDx Basic Information, Manufacturing Base and Competitors
Table 42. GeneDx Major Business
Table 43. GeneDx Neonatal Genetic Disease Diagnosis Product and Services
Table 44. GeneDx Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GeneDx Recent Developments/Updates
Table 46. GeneDx Competitive Strengths & Weaknesses
Table 47. Revvity Basic Information, Manufacturing Base and Competitors
Table 48. Revvity Major Business
Table 49. Revvity Neonatal Genetic Disease Diagnosis Product and Services
Table 50. Revvity Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Revvity Recent Developments/Updates
Table 52. Revvity Competitive Strengths & Weaknesses
Table 53. Labcorp Basic Information, Manufacturing Base and Competitors
Table 54. Labcorp Major Business
Table 55. Labcorp Neonatal Genetic Disease Diagnosis Product and Services
Table 56. Labcorp Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Labcorp Recent Developments/Updates
Table 58. Labcorp Competitive Strengths & Weaknesses
Table 59. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 60. Quest Diagnostics Major Business
Table 61. Quest Diagnostics Neonatal Genetic Disease Diagnosis Product and Services
Table 62. Quest Diagnostics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Quest Diagnostics Recent Developments/Updates
Table 64. Quest Diagnostics Competitive Strengths & Weaknesses
Table 65. Centogene Basic Information, Manufacturing Base and Competitors
Table 66. Centogene Major Business
Table 67. Centogene Neonatal Genetic Disease Diagnosis Product and Services
Table 68. Centogene Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Centogene Recent Developments/Updates
Table 70. Centogene Competitive Strengths & Weaknesses
Table 71. Baylor Genetics Basic Information, Manufacturing Base and Competitors
Table 72. Baylor Genetics Major Business
Table 73. Baylor Genetics Neonatal Genetic Disease Diagnosis Product and Services
Table 74. Baylor Genetics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Baylor Genetics Recent Developments/Updates
Table 76. Baylor Genetics Competitive Strengths & Weaknesses
Table 77. Fulgent Genetics Basic Information, Manufacturing Base and Competitors
Table 78. Fulgent Genetics Major Business
Table 79. Fulgent Genetics Neonatal Genetic Disease Diagnosis Product and Services
Table 80. Fulgent Genetics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Fulgent Genetics Recent Developments/Updates
Table 82. Fulgent Genetics Competitive Strengths & Weaknesses
Table 83. ARUP Laboratories Basic Information, Manufacturing Base and Competitors
Table 84. ARUP Laboratories Major Business
Table 85. ARUP Laboratories Neonatal Genetic Disease Diagnosis Product and Services
Table 86. ARUP Laboratories Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. ARUP Laboratories Recent Developments/Updates
Table 88. ARUP Laboratories Competitive Strengths & Weaknesses
Table 89. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 90. BGI Genomics Major Business
Table 91. BGI Genomics Neonatal Genetic Disease Diagnosis Product and Services
Table 92. BGI Genomics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. BGI Genomics Recent Developments/Updates
Table 94. BGI Genomics Competitive Strengths & Weaknesses
Table 95. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 96. Berry Genomics Major Business
Table 97. Berry Genomics Neonatal Genetic Disease Diagnosis Product and Services
Table 98. Berry Genomics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Berry Genomics Recent Developments/Updates
Table 100. Berry Genomics Competitive Strengths & Weaknesses
Table 101. Annoroad Gene Technology Basic Information, Manufacturing Base and Competitors
Table 102. Annoroad Gene Technology Major Business
Table 103. Annoroad Gene Technology Neonatal Genetic Disease Diagnosis Product and Services
Table 104. Annoroad Gene Technology Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Annoroad Gene Technology Recent Developments/Updates
Table 106. Annoroad Gene Technology Competitive Strengths & Weaknesses
Table 107. CapitalBio Technology Basic Information, Manufacturing Base and Competitors
Table 108. CapitalBio Technology Major Business
Table 109. CapitalBio Technology Neonatal Genetic Disease Diagnosis Product and Services
Table 110. CapitalBio Technology Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. CapitalBio Technology Recent Developments/Updates
Table 112. CapitalBio Technology Competitive Strengths & Weaknesses
Table 113. KingMed Diagnostics Basic Information, Manufacturing Base and Competitors
Table 114. KingMed Diagnostics Major Business
Table 115. KingMed Diagnostics Neonatal Genetic Disease Diagnosis Product and Services
Table 116. KingMed Diagnostics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. KingMed Diagnostics Recent Developments/Updates
Table 118. KingMed Diagnostics Competitive Strengths & Weaknesses
Table 119. Novogene Basic Information, Manufacturing Base and Competitors
Table 120. Novogene Major Business
Table 121. Novogene Neonatal Genetic Disease Diagnosis Product and Services
Table 122. Novogene Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Novogene Recent Developments/Updates
Table 124. Novogene Competitive Strengths & Weaknesses
Table 125. Da An Gene Basic Information, Manufacturing Base and Competitors
Table 126. Da An Gene Major Business
Table 127. Da An Gene Neonatal Genetic Disease Diagnosis Product and Services
Table 128. Da An Gene Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Da An Gene Recent Developments/Updates
Table 130. Da An Gene Competitive Strengths & Weaknesses
Table 131. Global Key Players of Neonatal Genetic Disease Diagnosis Upstream (Raw Materials)
Table 132. Global Neonatal Genetic Disease Diagnosis Typical Customers
Table 1. World Neonatal Genetic Disease Diagnosis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Neonatal Genetic Disease Diagnosis Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Neonatal Genetic Disease Diagnosis Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Neonatal Genetic Disease Diagnosis Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Neonatal Genetic Disease Diagnosis Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neonatal Genetic Disease Diagnosis Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Neonatal Genetic Disease Diagnosis Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Neonatal Genetic Disease Diagnosis Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Neonatal Genetic Disease Diagnosis Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Neonatal Genetic Disease Diagnosis Players in 2025
Table 12. World Neonatal Genetic Disease Diagnosis Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Neonatal Genetic Disease Diagnosis Company Evaluation Quadrant
Table 14. Head Office of Key Neonatal Genetic Disease Diagnosis Players
Table 15. Neonatal Genetic Disease Diagnosis Market: Company Product Type Footprint
Table 16. Neonatal Genetic Disease Diagnosis Market: Company Product Application Footprint
Table 17. Neonatal Genetic Disease Diagnosis Mergers & Acquisitions Activity
Table 18. United States VS China Neonatal Genetic Disease Diagnosis Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Neonatal Genetic Disease Diagnosis Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Neonatal Genetic Disease Diagnosis Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neonatal Genetic Disease Diagnosis Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Neonatal Genetic Disease Diagnosis Revenue Market Share (2021-2026)
Table 23. China Based Neonatal Genetic Disease Diagnosis Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neonatal Genetic Disease Diagnosis Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Neonatal Genetic Disease Diagnosis Revenue Market Share (2021-2026)
Table 26. Rest of World Based Neonatal Genetic Disease Diagnosis Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Neonatal Genetic Disease Diagnosis Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Neonatal Genetic Disease Diagnosis Revenue Market Share (2021-2026)
Table 29. World Neonatal Genetic Disease Diagnosis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Neonatal Genetic Disease Diagnosis Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Neonatal Genetic Disease Diagnosis Market Size by Type (2027-2032) & (USD Million)
Table 32. World Neonatal Genetic Disease Diagnosis Market Size by Disease Coverage, (USD Million), 2021 & 2025 & 2032
Table 33. World Neonatal Genetic Disease Diagnosis Market Size Value by Disease Coverage (2021-2026) & (USD Million)
Table 34. World Neonatal Genetic Disease Diagnosis Market Size by Disease Coverage (2027-2032) & (USD Million)
Table 35. World Neonatal Genetic Disease Diagnosis Market Size by Turnaround Time, (USD Million), 2021 & 2025 & 2032
Table 36. World Neonatal Genetic Disease Diagnosis Market Size Value by Turnaround Time (2021-2026) & (USD Million)
Table 37. World Neonatal Genetic Disease Diagnosis Market Size by Turnaround Time (2027-2032) & (USD Million)
Table 38. World Neonatal Genetic Disease Diagnosis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Neonatal Genetic Disease Diagnosis Market Size by Application (2021-2026) & (USD Million)
Table 40. World Neonatal Genetic Disease Diagnosis Market Size by Application (2027-2032) & (USD Million)
Table 41. GeneDx Basic Information, Manufacturing Base and Competitors
Table 42. GeneDx Major Business
Table 43. GeneDx Neonatal Genetic Disease Diagnosis Product and Services
Table 44. GeneDx Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GeneDx Recent Developments/Updates
Table 46. GeneDx Competitive Strengths & Weaknesses
Table 47. Revvity Basic Information, Manufacturing Base and Competitors
Table 48. Revvity Major Business
Table 49. Revvity Neonatal Genetic Disease Diagnosis Product and Services
Table 50. Revvity Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Revvity Recent Developments/Updates
Table 52. Revvity Competitive Strengths & Weaknesses
Table 53. Labcorp Basic Information, Manufacturing Base and Competitors
Table 54. Labcorp Major Business
Table 55. Labcorp Neonatal Genetic Disease Diagnosis Product and Services
Table 56. Labcorp Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Labcorp Recent Developments/Updates
Table 58. Labcorp Competitive Strengths & Weaknesses
Table 59. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 60. Quest Diagnostics Major Business
Table 61. Quest Diagnostics Neonatal Genetic Disease Diagnosis Product and Services
Table 62. Quest Diagnostics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Quest Diagnostics Recent Developments/Updates
Table 64. Quest Diagnostics Competitive Strengths & Weaknesses
Table 65. Centogene Basic Information, Manufacturing Base and Competitors
Table 66. Centogene Major Business
Table 67. Centogene Neonatal Genetic Disease Diagnosis Product and Services
Table 68. Centogene Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Centogene Recent Developments/Updates
Table 70. Centogene Competitive Strengths & Weaknesses
Table 71. Baylor Genetics Basic Information, Manufacturing Base and Competitors
Table 72. Baylor Genetics Major Business
Table 73. Baylor Genetics Neonatal Genetic Disease Diagnosis Product and Services
Table 74. Baylor Genetics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Baylor Genetics Recent Developments/Updates
Table 76. Baylor Genetics Competitive Strengths & Weaknesses
Table 77. Fulgent Genetics Basic Information, Manufacturing Base and Competitors
Table 78. Fulgent Genetics Major Business
Table 79. Fulgent Genetics Neonatal Genetic Disease Diagnosis Product and Services
Table 80. Fulgent Genetics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Fulgent Genetics Recent Developments/Updates
Table 82. Fulgent Genetics Competitive Strengths & Weaknesses
Table 83. ARUP Laboratories Basic Information, Manufacturing Base and Competitors
Table 84. ARUP Laboratories Major Business
Table 85. ARUP Laboratories Neonatal Genetic Disease Diagnosis Product and Services
Table 86. ARUP Laboratories Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. ARUP Laboratories Recent Developments/Updates
Table 88. ARUP Laboratories Competitive Strengths & Weaknesses
Table 89. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 90. BGI Genomics Major Business
Table 91. BGI Genomics Neonatal Genetic Disease Diagnosis Product and Services
Table 92. BGI Genomics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. BGI Genomics Recent Developments/Updates
Table 94. BGI Genomics Competitive Strengths & Weaknesses
Table 95. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 96. Berry Genomics Major Business
Table 97. Berry Genomics Neonatal Genetic Disease Diagnosis Product and Services
Table 98. Berry Genomics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Berry Genomics Recent Developments/Updates
Table 100. Berry Genomics Competitive Strengths & Weaknesses
Table 101. Annoroad Gene Technology Basic Information, Manufacturing Base and Competitors
Table 102. Annoroad Gene Technology Major Business
Table 103. Annoroad Gene Technology Neonatal Genetic Disease Diagnosis Product and Services
Table 104. Annoroad Gene Technology Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Annoroad Gene Technology Recent Developments/Updates
Table 106. Annoroad Gene Technology Competitive Strengths & Weaknesses
Table 107. CapitalBio Technology Basic Information, Manufacturing Base and Competitors
Table 108. CapitalBio Technology Major Business
Table 109. CapitalBio Technology Neonatal Genetic Disease Diagnosis Product and Services
Table 110. CapitalBio Technology Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. CapitalBio Technology Recent Developments/Updates
Table 112. CapitalBio Technology Competitive Strengths & Weaknesses
Table 113. KingMed Diagnostics Basic Information, Manufacturing Base and Competitors
Table 114. KingMed Diagnostics Major Business
Table 115. KingMed Diagnostics Neonatal Genetic Disease Diagnosis Product and Services
Table 116. KingMed Diagnostics Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. KingMed Diagnostics Recent Developments/Updates
Table 118. KingMed Diagnostics Competitive Strengths & Weaknesses
Table 119. Novogene Basic Information, Manufacturing Base and Competitors
Table 120. Novogene Major Business
Table 121. Novogene Neonatal Genetic Disease Diagnosis Product and Services
Table 122. Novogene Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Novogene Recent Developments/Updates
Table 124. Novogene Competitive Strengths & Weaknesses
Table 125. Da An Gene Basic Information, Manufacturing Base and Competitors
Table 126. Da An Gene Major Business
Table 127. Da An Gene Neonatal Genetic Disease Diagnosis Product and Services
Table 128. Da An Gene Neonatal Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Da An Gene Recent Developments/Updates
Table 130. Da An Gene Competitive Strengths & Weaknesses
Table 131. Global Key Players of Neonatal Genetic Disease Diagnosis Upstream (Raw Materials)
Table 132. Global Neonatal Genetic Disease Diagnosis Typical Customers
LIST OF FIGURES
Figure 1. Neonatal Genetic Disease Diagnosis Picture
Figure 2. World Neonatal Genetic Disease Diagnosis Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Neonatal Genetic Disease Diagnosis Total Revenue (2021-2032) & (USD Million)
Figure 4. World Neonatal Genetic Disease Diagnosis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Neonatal Genetic Disease Diagnosis Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 13. Neonatal Genetic Disease Diagnosis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 16. World Neonatal Genetic Disease Diagnosis Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 18. China Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 23. India Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Neonatal Genetic Disease Diagnosis by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neonatal Genetic Disease Diagnosis Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neonatal Genetic Disease Diagnosis Markets in 2025
Figure 27. United States VS China: Neonatal Genetic Disease Diagnosis Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Neonatal Genetic Disease Diagnosis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Neonatal Genetic Disease Diagnosis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Type in 2025
Figure 31. Targeted Gene Panel Testing
Figure 32. Whole Exome Sequencing
Figure 33. Whole Genome Sequencing
Figure 34. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Type (2021-2032)
Figure 35. World Neonatal Genetic Disease Diagnosis Market Size by Disease Coverage, (USD Million), 2021 & 2025 & 2032
Figure 36. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Disease Coverage in 2025
Figure 37. Inherited Metabolic Disease Diagnosis
Figure 38. Primary Immunodeficiency Diagnosis
Figure 39. Neuromuscular and Developmental Disorder Diagnosis
Figure 40. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Disease Coverage (2021-2032)
Figure 41. World Neonatal Genetic Disease Diagnosis Market Size by Turnaround Time, (USD Million), 2021 & 2025 & 2032
Figure 42. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Turnaround Time in 2025
Figure 43. Rapid Diagnosis??7 days?
Figure 44. Standard Diagnosis?8?21 days?
Figure 45. Extended Diagnosis??21 days?
Figure 46. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Turnaround Time (2021-2032)
Figure 47. World Neonatal Genetic Disease Diagnosis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Application in 2025
Figure 49. Hospitals
Figure 50. Third-Party Clinical Laboratories
Figure 51. Public Health Screening Centers
Figure 52. Other
Figure 53. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Application (2021-2032)
Figure 54. Neonatal Genetic Disease Diagnosis Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Neonatal Genetic Disease Diagnosis Picture
Figure 2. World Neonatal Genetic Disease Diagnosis Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Neonatal Genetic Disease Diagnosis Total Revenue (2021-2032) & (USD Million)
Figure 4. World Neonatal Genetic Disease Diagnosis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Neonatal Genetic Disease Diagnosis Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Neonatal Genetic Disease Diagnosis Revenue (2021-2032) & (USD Million)
Figure 13. Neonatal Genetic Disease Diagnosis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 16. World Neonatal Genetic Disease Diagnosis Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 18. China Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 23. India Neonatal Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Neonatal Genetic Disease Diagnosis by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neonatal Genetic Disease Diagnosis Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neonatal Genetic Disease Diagnosis Markets in 2025
Figure 27. United States VS China: Neonatal Genetic Disease Diagnosis Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Neonatal Genetic Disease Diagnosis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Neonatal Genetic Disease Diagnosis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Type in 2025
Figure 31. Targeted Gene Panel Testing
Figure 32. Whole Exome Sequencing
Figure 33. Whole Genome Sequencing
Figure 34. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Type (2021-2032)
Figure 35. World Neonatal Genetic Disease Diagnosis Market Size by Disease Coverage, (USD Million), 2021 & 2025 & 2032
Figure 36. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Disease Coverage in 2025
Figure 37. Inherited Metabolic Disease Diagnosis
Figure 38. Primary Immunodeficiency Diagnosis
Figure 39. Neuromuscular and Developmental Disorder Diagnosis
Figure 40. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Disease Coverage (2021-2032)
Figure 41. World Neonatal Genetic Disease Diagnosis Market Size by Turnaround Time, (USD Million), 2021 & 2025 & 2032
Figure 42. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Turnaround Time in 2025
Figure 43. Rapid Diagnosis??7 days?
Figure 44. Standard Diagnosis?8?21 days?
Figure 45. Extended Diagnosis??21 days?
Figure 46. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Turnaround Time (2021-2032)
Figure 47. World Neonatal Genetic Disease Diagnosis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Application in 2025
Figure 49. Hospitals
Figure 50. Third-Party Clinical Laboratories
Figure 51. Public Health Screening Centers
Figure 52. Other
Figure 53. World Neonatal Genetic Disease Diagnosis Market Size Market Share by Application (2021-2032)
Figure 54. Neonatal Genetic Disease Diagnosis Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
